Loading…
Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes
Background Dexamethasone is a potent glucocorticoid with anti‐inflammatory effects. Dexamethasone can protect ischemic cardiomyocytes from apoptosis. To apply the anti‐apoptotic effect of dexamethasone to ischemic disease gene therapy, dexamethasone‐conjugated polyethylenimine (PEI‐Dexa) was synthes...
Saved in:
| Published in: | The journal of gene medicine 2009-06, Vol.11 (6), p.515-522 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473 |
| container_end_page | 522 |
| container_issue | 6 |
| container_start_page | 515 |
| container_title | The journal of gene medicine |
| container_volume | 11 |
| creator | Kim, Hyunjung Kim, Hyun Ah Bae, Yun Mi Choi, Joon Sig Lee, Minhyung |
| description | Background
Dexamethasone is a potent glucocorticoid with anti‐inflammatory effects. Dexamethasone can protect ischemic cardiomyocytes from apoptosis. To apply the anti‐apoptotic effect of dexamethasone to ischemic disease gene therapy, dexamethasone‐conjugated polyethylenimine (PEI‐Dexa) was synthesized and evaluated as an anti‐apoptotic gene carrier.
Methods
PEI‐Dexa was synthesized with low molecular weight polyethylenimine (PEI2K, 2 kDa). The transfection efficiency and cytotoxicity of PEI‐Dexa were evaluated by luciferase assay and the MTT assay. To evaluate the anti‐apoptotic effect, PEI‐Dexa/DNA complex was transfected into cells and the cells were treated with H2O2. Cell viability and apoptosis level were measured by the MTT assay and caspase‐3 assay, respectively.
Results
A transfection assay into H9C2 rat cardiomyocytes showed that PEI‐Dexa had the highest transfection efficiency at an 8 : 1 weight ratio (PEI‐Dexa/DNA). At this ratio, PEI‐Dexa had higher transfection efficiency than high molecular polyethylenimine (PEI25K, 25 kDa) and PEI2K. In addition, the cytotoxicity of PEI‐Dexa was lower than that of PEI25K. To evaluate the anti‐apoptotic effect, PEI‐Dexa/pSV‐Luc or PEI2K/pSV‐Luc was transfected into H9C2 cells and the cells were treated with H2O2. PEI‐Dexa was found to reduce caspase‐3 activity and increase cell viability compared to PEI2K. Heme oxygenase‐1 (HO‐1) can protect ischemic cardiomyocytes from apoptosis. Therefore, pSV‐HO‐1 was cloned and transfected into H9C2 cells using PEI‐Dexa. The cells transfected with PEI‐Dexa/pSV‐HO‐1 complex had lower caspase‐3 activity and higher viability than the cells transfected with PEI‐Dexa/pSV‐Luc complex after the H2O2 treatment.
Conclusions
PEI‐Dexa is an efficient gene carrier with an anti‐apoptotic effect and may be useful for anti‐apoptotic gene therapy in combination with pSV‐HO‐1. Copyright © 2009 John Wiley & Sons, Ltd. |
| doi_str_mv | 10.1002/jgm.1320 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883025259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3924186921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473</originalsourceid><addsrcrecordid>eNp10V2L1DAUBuAiiruugr9ACl7oTdd8tE1yKbM6o4yKoijehDQ9nc3YJjVJ3e2_N2WKguBVwsnDSzhvlj3G6BIjRF4cD8MlpgTdyc5xRXBBSFXeTXckRFEK_u0sexDCESHMOBf3szMsKMK0FufZryu4VQPEaxWchUI7e5wOKkKbj66f03zuwZrBWMhVyJXNoeuMNmBjfoA01Mp7Az6_MfF6eVY2mkKNbowuGr1o0DGPboGtccPs9BwhPMzudaoP8Gg9L7Ivr1993uyK_Yftm83LfaEpr1GhS9zUSCMQuqmVblhJta6rrgLS0Y4j3RLVguCUk4oJzjAXmtUKNVgRgUtGL7Jnp9zRu58ThCgHEzT0vbLgpiA5p4hUpBJJPv1HHt3kbfqcxKxitRC8xEk9PyntXQgeOjl6Myg_S4zkUoVMVcilikSfrIFTM0D7F667T6A4gRvTw_zfIPl2-24NXL0JEW7_eOV_yJpRVsmv77fy01bsd98_buSO_gbx_aNG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757699841</pqid></control><display><type>article</type><title>Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Kim, Hyunjung ; Kim, Hyun Ah ; Bae, Yun Mi ; Choi, Joon Sig ; Lee, Minhyung</creator><creatorcontrib>Kim, Hyunjung ; Kim, Hyun Ah ; Bae, Yun Mi ; Choi, Joon Sig ; Lee, Minhyung</creatorcontrib><description>Background
Dexamethasone is a potent glucocorticoid with anti‐inflammatory effects. Dexamethasone can protect ischemic cardiomyocytes from apoptosis. To apply the anti‐apoptotic effect of dexamethasone to ischemic disease gene therapy, dexamethasone‐conjugated polyethylenimine (PEI‐Dexa) was synthesized and evaluated as an anti‐apoptotic gene carrier.
Methods
PEI‐Dexa was synthesized with low molecular weight polyethylenimine (PEI2K, 2 kDa). The transfection efficiency and cytotoxicity of PEI‐Dexa were evaluated by luciferase assay and the MTT assay. To evaluate the anti‐apoptotic effect, PEI‐Dexa/DNA complex was transfected into cells and the cells were treated with H2O2. Cell viability and apoptosis level were measured by the MTT assay and caspase‐3 assay, respectively.
Results
A transfection assay into H9C2 rat cardiomyocytes showed that PEI‐Dexa had the highest transfection efficiency at an 8 : 1 weight ratio (PEI‐Dexa/DNA). At this ratio, PEI‐Dexa had higher transfection efficiency than high molecular polyethylenimine (PEI25K, 25 kDa) and PEI2K. In addition, the cytotoxicity of PEI‐Dexa was lower than that of PEI25K. To evaluate the anti‐apoptotic effect, PEI‐Dexa/pSV‐Luc or PEI2K/pSV‐Luc was transfected into H9C2 cells and the cells were treated with H2O2. PEI‐Dexa was found to reduce caspase‐3 activity and increase cell viability compared to PEI2K. Heme oxygenase‐1 (HO‐1) can protect ischemic cardiomyocytes from apoptosis. Therefore, pSV‐HO‐1 was cloned and transfected into H9C2 cells using PEI‐Dexa. The cells transfected with PEI‐Dexa/pSV‐HO‐1 complex had lower caspase‐3 activity and higher viability than the cells transfected with PEI‐Dexa/pSV‐Luc complex after the H2O2 treatment.
Conclusions
PEI‐Dexa is an efficient gene carrier with an anti‐apoptotic effect and may be useful for anti‐apoptotic gene therapy in combination with pSV‐HO‐1. Copyright © 2009 John Wiley & Sons, Ltd.</description><identifier>ISSN: 1099-498X</identifier><identifier>ISSN: 1521-2254</identifier><identifier>EISSN: 1521-2254</identifier><identifier>DOI: 10.1002/jgm.1320</identifier><identifier>PMID: 19301369</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Animals ; Anti-Inflammatory Agents - administration & dosage ; Apoptosis ; Caspase 3 - metabolism ; Cells, Cultured ; dexamethasone ; Dexamethasone - administration & dosage ; Enzyme-Linked Immunosorbent Assay ; gene carrier ; Gene therapy ; Gene Transfer Techniques ; heme oxygenase-1 ; hydrogen peroxide ; Myocytes, Cardiac - metabolism ; Polyethyleneimine - chemistry ; Polyethyleneimine - toxicity ; polyethylenimine ; Rats ; Transfection</subject><ispartof>The journal of gene medicine, 2009-06, Vol.11 (6), p.515-522</ispartof><rights>Copyright © 2009 John Wiley & Sons, Ltd.</rights><rights>(c) 2009 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473</citedby><cites>FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19301369$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Hyunjung</creatorcontrib><creatorcontrib>Kim, Hyun Ah</creatorcontrib><creatorcontrib>Bae, Yun Mi</creatorcontrib><creatorcontrib>Choi, Joon Sig</creatorcontrib><creatorcontrib>Lee, Minhyung</creatorcontrib><title>Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes</title><title>The journal of gene medicine</title><addtitle>J. Gene Med</addtitle><description>Background
Dexamethasone is a potent glucocorticoid with anti‐inflammatory effects. Dexamethasone can protect ischemic cardiomyocytes from apoptosis. To apply the anti‐apoptotic effect of dexamethasone to ischemic disease gene therapy, dexamethasone‐conjugated polyethylenimine (PEI‐Dexa) was synthesized and evaluated as an anti‐apoptotic gene carrier.
Methods
PEI‐Dexa was synthesized with low molecular weight polyethylenimine (PEI2K, 2 kDa). The transfection efficiency and cytotoxicity of PEI‐Dexa were evaluated by luciferase assay and the MTT assay. To evaluate the anti‐apoptotic effect, PEI‐Dexa/DNA complex was transfected into cells and the cells were treated with H2O2. Cell viability and apoptosis level were measured by the MTT assay and caspase‐3 assay, respectively.
Results
A transfection assay into H9C2 rat cardiomyocytes showed that PEI‐Dexa had the highest transfection efficiency at an 8 : 1 weight ratio (PEI‐Dexa/DNA). At this ratio, PEI‐Dexa had higher transfection efficiency than high molecular polyethylenimine (PEI25K, 25 kDa) and PEI2K. In addition, the cytotoxicity of PEI‐Dexa was lower than that of PEI25K. To evaluate the anti‐apoptotic effect, PEI‐Dexa/pSV‐Luc or PEI2K/pSV‐Luc was transfected into H9C2 cells and the cells were treated with H2O2. PEI‐Dexa was found to reduce caspase‐3 activity and increase cell viability compared to PEI2K. Heme oxygenase‐1 (HO‐1) can protect ischemic cardiomyocytes from apoptosis. Therefore, pSV‐HO‐1 was cloned and transfected into H9C2 cells using PEI‐Dexa. The cells transfected with PEI‐Dexa/pSV‐HO‐1 complex had lower caspase‐3 activity and higher viability than the cells transfected with PEI‐Dexa/pSV‐Luc complex after the H2O2 treatment.
Conclusions
PEI‐Dexa is an efficient gene carrier with an anti‐apoptotic effect and may be useful for anti‐apoptotic gene therapy in combination with pSV‐HO‐1. Copyright © 2009 John Wiley & Sons, Ltd.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - administration & dosage</subject><subject>Apoptosis</subject><subject>Caspase 3 - metabolism</subject><subject>Cells, Cultured</subject><subject>dexamethasone</subject><subject>Dexamethasone - administration & dosage</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>gene carrier</subject><subject>Gene therapy</subject><subject>Gene Transfer Techniques</subject><subject>heme oxygenase-1</subject><subject>hydrogen peroxide</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Polyethyleneimine - chemistry</subject><subject>Polyethyleneimine - toxicity</subject><subject>polyethylenimine</subject><subject>Rats</subject><subject>Transfection</subject><issn>1099-498X</issn><issn>1521-2254</issn><issn>1521-2254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp10V2L1DAUBuAiiruugr9ACl7oTdd8tE1yKbM6o4yKoijehDQ9nc3YJjVJ3e2_N2WKguBVwsnDSzhvlj3G6BIjRF4cD8MlpgTdyc5xRXBBSFXeTXckRFEK_u0sexDCESHMOBf3szMsKMK0FufZryu4VQPEaxWchUI7e5wOKkKbj66f03zuwZrBWMhVyJXNoeuMNmBjfoA01Mp7Az6_MfF6eVY2mkKNbowuGr1o0DGPboGtccPs9BwhPMzudaoP8Gg9L7Ivr1993uyK_Yftm83LfaEpr1GhS9zUSCMQuqmVblhJta6rrgLS0Y4j3RLVguCUk4oJzjAXmtUKNVgRgUtGL7Jnp9zRu58ThCgHEzT0vbLgpiA5p4hUpBJJPv1HHt3kbfqcxKxitRC8xEk9PyntXQgeOjl6Myg_S4zkUoVMVcilikSfrIFTM0D7F667T6A4gRvTw_zfIPl2-24NXL0JEW7_eOV_yJpRVsmv77fy01bsd98_buSO_gbx_aNG</recordid><startdate>200906</startdate><enddate>200906</enddate><creator>Kim, Hyunjung</creator><creator>Kim, Hyun Ah</creator><creator>Bae, Yun Mi</creator><creator>Choi, Joon Sig</creator><creator>Lee, Minhyung</creator><general>John Wiley & Sons, Ltd</general><general>Wiley Periodicals Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7QO</scope></search><sort><creationdate>200906</creationdate><title>Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes</title><author>Kim, Hyunjung ; Kim, Hyun Ah ; Bae, Yun Mi ; Choi, Joon Sig ; Lee, Minhyung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - administration & dosage</topic><topic>Apoptosis</topic><topic>Caspase 3 - metabolism</topic><topic>Cells, Cultured</topic><topic>dexamethasone</topic><topic>Dexamethasone - administration & dosage</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>gene carrier</topic><topic>Gene therapy</topic><topic>Gene Transfer Techniques</topic><topic>heme oxygenase-1</topic><topic>hydrogen peroxide</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Polyethyleneimine - chemistry</topic><topic>Polyethyleneimine - toxicity</topic><topic>polyethylenimine</topic><topic>Rats</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Hyunjung</creatorcontrib><creatorcontrib>Kim, Hyun Ah</creatorcontrib><creatorcontrib>Bae, Yun Mi</creatorcontrib><creatorcontrib>Choi, Joon Sig</creatorcontrib><creatorcontrib>Lee, Minhyung</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><jtitle>The journal of gene medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Hyunjung</au><au>Kim, Hyun Ah</au><au>Bae, Yun Mi</au><au>Choi, Joon Sig</au><au>Lee, Minhyung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes</atitle><jtitle>The journal of gene medicine</jtitle><addtitle>J. Gene Med</addtitle><date>2009-06</date><risdate>2009</risdate><volume>11</volume><issue>6</issue><spage>515</spage><epage>522</epage><pages>515-522</pages><issn>1099-498X</issn><issn>1521-2254</issn><eissn>1521-2254</eissn><abstract>Background
Dexamethasone is a potent glucocorticoid with anti‐inflammatory effects. Dexamethasone can protect ischemic cardiomyocytes from apoptosis. To apply the anti‐apoptotic effect of dexamethasone to ischemic disease gene therapy, dexamethasone‐conjugated polyethylenimine (PEI‐Dexa) was synthesized and evaluated as an anti‐apoptotic gene carrier.
Methods
PEI‐Dexa was synthesized with low molecular weight polyethylenimine (PEI2K, 2 kDa). The transfection efficiency and cytotoxicity of PEI‐Dexa were evaluated by luciferase assay and the MTT assay. To evaluate the anti‐apoptotic effect, PEI‐Dexa/DNA complex was transfected into cells and the cells were treated with H2O2. Cell viability and apoptosis level were measured by the MTT assay and caspase‐3 assay, respectively.
Results
A transfection assay into H9C2 rat cardiomyocytes showed that PEI‐Dexa had the highest transfection efficiency at an 8 : 1 weight ratio (PEI‐Dexa/DNA). At this ratio, PEI‐Dexa had higher transfection efficiency than high molecular polyethylenimine (PEI25K, 25 kDa) and PEI2K. In addition, the cytotoxicity of PEI‐Dexa was lower than that of PEI25K. To evaluate the anti‐apoptotic effect, PEI‐Dexa/pSV‐Luc or PEI2K/pSV‐Luc was transfected into H9C2 cells and the cells were treated with H2O2. PEI‐Dexa was found to reduce caspase‐3 activity and increase cell viability compared to PEI2K. Heme oxygenase‐1 (HO‐1) can protect ischemic cardiomyocytes from apoptosis. Therefore, pSV‐HO‐1 was cloned and transfected into H9C2 cells using PEI‐Dexa. The cells transfected with PEI‐Dexa/pSV‐HO‐1 complex had lower caspase‐3 activity and higher viability than the cells transfected with PEI‐Dexa/pSV‐Luc complex after the H2O2 treatment.
Conclusions
PEI‐Dexa is an efficient gene carrier with an anti‐apoptotic effect and may be useful for anti‐apoptotic gene therapy in combination with pSV‐HO‐1. Copyright © 2009 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>19301369</pmid><doi>10.1002/jgm.1320</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1099-498X |
| ispartof | The journal of gene medicine, 2009-06, Vol.11 (6), p.515-522 |
| issn | 1099-498X 1521-2254 1521-2254 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_883025259 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Animals Anti-Inflammatory Agents - administration & dosage Apoptosis Caspase 3 - metabolism Cells, Cultured dexamethasone Dexamethasone - administration & dosage Enzyme-Linked Immunosorbent Assay gene carrier Gene therapy Gene Transfer Techniques heme oxygenase-1 hydrogen peroxide Myocytes, Cardiac - metabolism Polyethyleneimine - chemistry Polyethyleneimine - toxicity polyethylenimine Rats Transfection |
| title | Dexamethasone-conjugated polyethylenimine as an efficient gene carrier with an anti-apoptotic effect to cardiomyocytes |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T13%3A36%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dexamethasone-conjugated%20polyethylenimine%20as%20an%20efficient%20gene%20carrier%20with%20an%20anti-apoptotic%20effect%20to%20cardiomyocytes&rft.jtitle=The%20journal%20of%20gene%20medicine&rft.au=Kim,%20Hyunjung&rft.date=2009-06&rft.volume=11&rft.issue=6&rft.spage=515&rft.epage=522&rft.pages=515-522&rft.issn=1099-498X&rft.eissn=1521-2254&rft_id=info:doi/10.1002/jgm.1320&rft_dat=%3Cproquest_cross%3E3924186921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3860-c41b60c0e9cb6acb743cc65f5e2f3f80cd2ade9838257987189c76a0b1a291473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1757699841&rft_id=info:pmid/19301369&rfr_iscdi=true |